Reumatoloxía
Servicio
Hospital del Bierzo
Ponferrada, EspañaPublicacións en colaboración con investigadores/as de Hospital del Bierzo (20)
2021
-
The Experience With Health Care of Patients With Inflammatory Arthritis: A Cross-sectional Survey Using the Instrument to Evaluate the Experience of Patients With Chronic Diseases
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, Vol. 27, Núm. 1, pp. 25-30
2015
-
Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients
Rheumatology International, Vol. 35, Núm. 12, pp. 2069-2078
-
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain
Seminars in Arthritis and Rheumatism, Vol. 44, Núm. 6, pp. 633-640
2014
-
Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis
BioMed Research International, Vol. 2014
-
Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients
Annals of the Rheumatic Diseases
-
Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy
Clinical and Experimental Rheumatology, Vol. 32, Núm. 2, pp. 231-236
-
Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy
Clinical and Experimental Rheumatology, Vol. 32, Núm. 2, pp. 218-224
-
IGF-1 and ADMA Levels Are Inversely Correlated in Nondiabetic Ankylosing Spondylitis Patients Undergoing Anti-TNF-Alpha Therapy
BioMed Research International, Vol. 2014
-
Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy
Clinical and Experimental Rheumatology, Vol. 32, Núm. 5, pp. 640-646
-
Patients with ankylosing spondylitis and low disease activity because of anti-TNF-Alpha therapy have higher TRAIL levels than controls: A potential compensatory effect
Mediators of Inflammation, Vol. 2014
2013
-
Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy
Clinical and Experimental Rheumatology, Vol. 31, Núm. 3, pp. 365-371
-
Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients
Annals of the Rheumatic Diseases
-
Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy
Clinical and Experimental Rheumatology, Vol. 31, Núm. 4, pp. 532-537
-
Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy
Clinical and Experimental Rheumatology, Vol. 31, Núm. 5, pp. 749-755
-
Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy
Clinical and Experimental Rheumatology, Vol. 31, Núm. 6, pp. 913-918
-
Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy
Clinical and Experimental Rheumatology, Vol. 31, Núm. 4, pp. 538-545
2012
-
TNF-alpha antagonist therapy improves insulin sensitivity: In non-diabetic ankylosing spondylitis patients
Clinical and Experimental Rheumatology, Vol. 30, Núm. 6, pp. 850-855
2008
-
Reacciones adversas relacionadas con la administración de inhibidores del TNF. Análisis de un registro de terapias biológicas
Reumatologia Clinica, Vol. 4, Núm. 3, pp. 90-95
2007
-
Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (BIOBADASER): Informe de la situación, 26 de enero de 2006
Reumatologia Clinica, Vol. 3, Núm. 1, pp. 4-20
2006
-
Switching TNF antagonists in patients with chronic arthritis: An observational study of 488 patients over a four-year period
Arthritis Research and Therapy, Vol. 8, Núm. 1